Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GK Investor Relations (GKIR) is a premier international investor relations and public relations firm with a specialized focus on the life sciences, healthcare, and technology industries. The firm provides comprehensive strategic advisory services, including financial communications, capital markets positioning, and crisis management, to both public and private companies. GKIR leverages its deep expertise and extensive network in the United States and Israel to enhance its clients' visibility and credibility among global institutional investors and analysts. The company is particularly recognized for its work with Israeli-based life science firms seeking to access international capital markets, such as NASDAQ. Their services encompass the full spectrum of investor engagement, from roadshow organization to quarterly earnings support and media relations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GK Investor Relations.